ACHV - ACHIEVE LIFE SCIENCES, INC.
2.65
-0.240 -9.057%
Share volume: 1,234,058
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$2.89
-0.24
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-07-2024 | 03-11-2025 | 05-13-2025 | 08-07-2025 | 11-06-2025 | 03-24-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.982 M | 8.431 M | 12.466 M | 12.190 M | 12.894 M | 12.563 M | 14.692 M | 14.731 M | |
| Selling general and admin | 3.183 M | 3.318 M | 4.857 M | 4.894 M | 5.797 M | 5.856 M | 9.372 M | 10.857 M | |
| Research and development | 2.799 M | 5.113 M | 7.609 M | 7.296 M | 7.097 M | 6.707 M | 5.320 M | 3.874 M | |
| Total expenses | 6.034 M | 8.431 M | 12.466 M | 12.759 M | 12.894 M | 12.660 M | 14.798 M | 14.528 M | |
| 39.72% | 47.86% | 2.35% | 1.06% | -1.81% | 16.89% | -1.82% | |||
| Operating income | -6.034 M | -8.431 M | -12.466 M | -12.759 M | -12.894 M | -12.660 M | -14.798 M | -14.528 M | |
| Ebit | -6.049 M | -8.490 M | -12.536 M | -12.645 M | -12.964 M | -12.719 M | -14.803 M | -14.838 M | |
| Pretax income | -6.494 M | -8.461 M | -12.512 M | -12.360 M | -12.827 M | -12.718 M | -14.441 M | -14.662 M | |
| 30.29% | 47.88% | -1.21% | 3.78% | -0.85% | 13.55% | 1.53% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.494 M | -8.461 M | -12.512 M | -12.360 M | -12.827 M | -12.718 M | -14.441 M | -14.662 M | |
| -30.29% | -47.88% | 1.21% | -3.78% | 0.85% | -13.55% | -1.53% |